Lantheus Holdings, Inc. (LNTH) News
Filter LNTH News Items
LNTH News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
LNTH News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest LNTH News From Around the Web
Below are the latest news stories about LANTHEUS HOLDINGS INC that investors may wish to consider to help them evaluate LNTH as an investment opportunity.
Lantheus to buy Life Molecular Imaging for $350M and additional payment on earn-outsMore on Lantheus |
Here’s What Lifted Lantheus Holdings (LNTH) in Q3ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The Fed’s rate cut in September contributed to a shift from large-cap generative AI winners to a broader range of market leadership, particularly in small-cap stocks. However, the strategy […] |
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical DevicesArtificial intelligence is the watchword for investors, but some analysts also see strength this year in the medical sector. Lantheus Holdings is a standout among medical device makers, and its devices use artificial intelligence. Based on its strong fundamentals, Lantheus stock's Relative Strength (RS) Rating crossed above a milestone as it got upgraded from 80 to 83 Tuesday. |
Lantheus Holdings, Inc. (LNTH): A Bull Case TheoryWe came across a bullish thesis on Lantheus Holdings, Inc. (LNTH) on Value Investing Subreddit Page by Small_Bodybuilder_12. In this article, we will summarize the bulls’ thesis on LNTH. Lantheus Holdings, Inc. (LNTH)’s share was trading at $90.98 as of Dec 10th. LNTH’s trailing and forward P/E were 15.11 and 11.79 respectively according to Yahoo Finance. Lantheus […] |
Is Weakness In Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?With its stock down 17% over the past month, it is easy to disregard Lantheus Holdings (NASDAQ:LNTH). However, a closer... |
LNTH: Initiating Coverage - A Glowing RecommendationBy John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT We are initiating coverage of Lantheus Holdings, Inc. (NASDAQ:LNTH) and assign a valuation of $134 per share. This valuation is based on our estimates for continued growth of Pylarify, Definity and TechneLite as well as long term opportunity in Alzheimer’s disease imaging and prostate cancer treatment among other strategic |
Why Lantheus Holdings, Inc. (LNTH) Is One of the Most Profitable Pharmaceutical Stocks Right NowWe recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against the other most profitable pharmaceutical stocks. The Pharmaceutical Industry: Growth, Innovation, and Emerging Challenges Healthcare, which includes numerous businesses that offer patient care, conduct […] |
Lantheus Holdings’ (LNTH) Radiopharmaceutical Pipeline Fuels Growth ExpectationsCarillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. After experiencing losses in the second quarter, small-cap stocks notably increased in the third quarter. The Russell 2000 Growth Index (up 8.41%) underperformed the Russell 2000 […] |
Why Lantheus Holdings Stock Won Big on WednesdayThe stock of radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) was a standout in the healthcare sector on Hump Day. The company saw its share price improve by almost 9% at market close, thanks to news of a shareholder-pleasing move. Well before market open, Lantheus announced the launch of a $250 million share repurchase program. |
Lantheus Announces Share Repurchase ProgramBEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its board of directors has authorized a program to repurchase up to $250 million of its common stock during the next twelve months. “With our strong financial position and the Board’s commitment to shareholder value, t |